Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1128.02
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Pamela M. Tuxworth has worked on the following 175 EPO patent applications which have been published in the last five years:

EP10824620

CARBONIC ANHYDRASE I SERVING AS NOVEL ANTIGEN TO BE USED FOR TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
A61P 1/04, A61P 37/06, A61P 43/00, C12N 5/0783, C12N 9/88, C12N 15/09, A61K 35/12, A61K 35/28, A61K 38/51, A61K 39/00
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11783675

ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO

IPC classification:
A61P 35/00, C07K 16/32, C12N 5/10, C12N 15/09, C12P 21/08, G01N 33/574, A61K 39/395, A61K 45/00
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11823616

HEPATITIS C VIRUS LIPOSOME VACCINE

IPC classification:
A61P 31/14, C07K 7/06, C12N 5/0783, C12N 15/117, A61K 9/127, A61K 39/29, A61K 39/39
Applicant:
Saitama Medical University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
PATENT GRANTED
EP11833368

METHODS FOR ESTIMATING GENOME-WIDE COPY NUMBER VARIATIONS

IPC classification:
G06F 19/00
Applicant:
Complete Genomics Inc
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12801801

BIOLOGICAL SAMPLE PRETREATMENT METHOD, METHOD FOR DETECTING RNA, AND PRETREATMENT KIT

IPC classification:
C07K 14/79, C12N 9/36, C12N 9/99, C12N 15/09, C12Q 1/68
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11832651

RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES

IPC classification:
A61P 31/16, C12N 7/04, C12N 15/09, A61K 31/711, A61K 35/76, A61K 39/145, A61K 48/00
Applicant:
Hokkaido University
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11792564

ANTI-TIM-3 ANTIBODY

IPC classification:
A61P 7/00, C07K 16/28, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08, A61K 39/00
Applicant:
Kyushu University
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11848634

METHOD FOR PRODUCING PROTEINS

IPC classification:
C12N 5/10, C12N 15/09, C12P 21/02
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11759544

NOVEL ANTIBODY HAVING MODIFICATION SITE INTRODUCED THEREIN, AND ANTIBODY FRAGMENT

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12182489

Anticonnexin polynucleotides as impaired wound healing compositions

IPC classification:
A61P 17/02, C12N 15/11, A61K 31/7105
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP12182487

Anticonnexin polynucleotides as impaired wound healing compositions

IPC classification:
A61P 17/02, C12N 15/11, A61K 31/7105
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP12748831

METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL SHEET

IPC classification:
A61P 27/02, C12N 5/071, C12N 5/10, A61K 35/44
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12711287

COMPOSITION FOR SYNTHESIZING PROTEIN WITH REDUCED LIPOPOLYSACCHARIDE CONTAMINATION, METHOD FOR PRODUCING PROTEIN USING SAID COMPOSITION

IPC classification:
C12N 15/09
Applicant:
University of Tokyo
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12765017

REGULATOR OF ANAPLASTIC STATE AND APPLICATIONS THEREFOR

IPC classification:
C07K 14/52, C12N 1/00, C12N 5/073, C12N 5/10, C12N 15/09
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11826607

NOVEL TESTING METHOD AND TESTING REAGENT FOR ANGIITIS

IPC classification:
G01N 33/564
Applicant:
Jichi Medical University
Applicant:
Chiba University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
PATENT GRANTED
EP13153125

Impaired wound healing compositions and treatments

IPC classification:
C07K 2/00, C07K 14/78, A61K 38/02
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12726165

COUPLING METHOD

IPC classification:
B82Y 15/00, G01N 33/487
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12722557

ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE ANTIBODY

IPC classification:
C07K 16/28, G01N 33/68, A61K 39/395
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11848424

PROTEIN PRODUCTION METHOD

IPC classification:
C07K 16/10, C07K 16/24, C07K 16/28, C12N 5/10, C12N 15/09, C12N 15/85, C12P 21/02, C12P 21/08
Applicant:
Inter-University Research Institute Corporation Research Organization of Information and Systems
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12818196

ANTIBODY FOR DETECTING EPITHELIAL OVARIAN CANCER MARKER AND METHOD FOR DIAGNOSING EPITHELIAL OVARIAN CANCER

IPC classification:
C07K 16/40, C12N 5/10, C12N 9/10, C12N 15/09, C12P 21/08, G01N 33/573, G01N 33/574
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12820579

CELL FOR USE IN IMMUNOTHERAPY WHICH CONTAINS MODIFIED NUCLEIC ACID CONSTRUCT ENCODING WILMS TUMOR GENE PRODUCT OR FRAGMENT THEREOF, METHOD FOR PRODUCING SAID CELL, AND SAID NUCLEIC ACID CONSTRUCT

IPC classification:
C07K 14/82, C12N 5/10, C12N 15/09, A61K 39/00
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12753551

HAIRPIN LOOP METHOD FOR DOUBLE STRAND POLYNUCLEOTIDE SEQUENCING USING TRANSMEMBRANE PORES

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12803735

SOLUBLE INTEGRIN ALPHA-4 MUTANT

IPC classification:
A61P 1/04, A61P 3/10, A61P 9/10, A61P 11/00, A61P 13/12, A61P 17/00, A61P 19/02, A61P 25/00, A61P 29/00, A61P 31/18, A61P 35/00, A61P 35/04, A61P 37/00, A61P 37/06, C07K 14/71, C07K 16/28, A61K 38/00, A61K 39/395
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12826199

CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS

IPC classification:
C12N 7/00, C12N 15/09, C12Q 1/02
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12829373

ANTIBODY CAPABLE OF BINDING TO SPECIFIC REGION OF PERIOSTIN, AND METHOD FOR MEASURING PERIOSTIN USING SAME

IPC classification:
C07K 16/28, G01N 33/53
Applicant:
Kurume University
Applicant:
Saga University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12774207

USE OF MYELIN BASIC PROTEIN AS A NOVEL GENETIC FACTOR FOR RHEUMATOID ARTHRITIS

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/53, G01N 33/564
Applicant:
Kyoto University
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP12792838

GENE TARGETING VECTOR, METHOD FOR MANUFACTURING SAME, AND METHOD FOR USING SAME

IPC classification:
C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12792225

PRODUCTION METHOD FOR ARTIFICIAL CANCER STEM CELL AND INDUCED DIFFERENTIATION METHOD THEREFOR

IPC classification:
C12N 5/10, C12N 15/09, C12Q 1/02
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12837508

METHOD FOR INDUCING OREXIN NEURON

IPC classification:
C12N 5/0735, C12N 5/0775, C12N 5/0793, C12N 5/0797, C12N 5/10, C12Q 1/02, G01N 33/15, G01N 33/50
Applicant:
University of Tokyo
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13187149

Enzyme-pore constructs

IPC classification:
C12N 9/12, C12N 9/22, C12N 9/52, C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP12835199

METHOD FOR PRODUCING TISSUE AND ORGAN

IPC classification:
C12N 5/00, C12N 5/10
Applicant:
Yokohama City University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12837488

METHOD FOR INDUCING HEPATOCELLULAR VARIATION, AND PRODUCTION METHOD FOR CHIMERIC NON-HUMAN ANIMAL HAVING HUMANIZED LIVER

IPC classification:
C12N 5/077, C12Q 1/02, G01N 33/15, G01N 33/48, A01K 67/027
Applicant:
Yokohama City University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12837799

METHOD FOR PRODUCING CORNEAL ENDOTHELIAL CELL

IPC classification:
A61P 27/02, C12N 5/10, C12N 15/09, A61K 35/44, A61L 27/00
Applicant:
Keio University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12779704

IMPROVED SUGAR-COATED LIPOSOME COMPOSITION

IPC classification:
A61P 35/00, C07K 14/705, A61K 9/127, A61K 31/7088, A61K 38/00, A61K 39/00, A61K 39/39, A61K 47/36, A61K 48/00
Applicant:
Tokai University Educational System
Applicant:
Sapporo Medical University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12752901

NOVEL VITAMIN D RECEPTOR MODULATOR WITH PARTIAL AGONIST ACTIVITY

IPC classification:
A61P 3/10, A61P 9/00, A61P 17/06, A61P 19/10, A61P 25/28, A61P 31/00, A61P 35/00, A61P 37/06, A61P 43/00, C07C 401/00, A61K 31/59
Applicant:
Nihon University
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP12829819

PRIMER SET, METHOD FOR AMPLIFYING TARGET NUCLEIC ACID SEQUENCE USING SAME, AND METHOD FOR DETECTING MUTATED NUCLEIC ACID USING SAME

IPC classification:
C12N 15/09, C12Q 1/68
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12845639

METHOD FOR CULTURING STEM CELL

IPC classification:
A61P 5/00, A61P 5/06, A61P 5/14, A61P 5/24, A61P 5/38, C12N 5/0735, A61K 35/12
Applicant:
Kabushiki Kaisha Riken
Applicant:
Sumitomo Chemical Company Limited
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14160760

Influenza antigen delivery vectors and constructs

IPC classification:
A61K 39/145, A61K 39/385
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13174963

Antibodies Against ERBB3 and Uses Thereof

IPC classification:
A61P 35/00, A61K 39/395
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12837264

METHOD FOR EVALUATING DRUG SENSITIVITY AND SUSCEPTIBILITY TO DISEASES BY ANALYZING GENE FOR PROTEIN CAPABLE OF BINDING TO CYCLIC-AMP-RESPONSIVE SEQUENCE

IPC classification:
C12N 15/09, C12Q 1/68
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13185830

Human immune therapies using a CD27 agonist alone or in combination with other immune modulators

IPC classification:
A61P 35/00, C07K 16/00, C07K 16/28, A61K 39/395
Applicant:
University of Southampton
Agent:
Boult Wade Tennant Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12852269

ANTI-HUMAN TROP-2 ANTIBODY EXHIBITING ANTITUMOR ACTIVITY IN VIVO

IPC classification:
A61P 35/00, C07K 16/30, C12N 15/09, C12P 21/08, G01N 33/53, A61K 39/395
Applicant:
LIVTECH, INC.
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12816096

METHOD FOR CHARACTERISING A POLYNUCELOTIDE BY USING A XPD HELICASE

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12860743

EXOSOME ANALYSIS METHOD, REAGENT FOR USE IN ANALYSIS OF EXOSOME, AND EXOSOME ANALYSIS APPARATUS

IPC classification:
G01N 33/53, G01N 33/532
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12767379

METHOD FOR PRODUCING SHEET-LIKE PANCREATIC ISLET

IPC classification:
C07K 14/47, C07K 14/705, C07K 16/28, C07K 17/14, C12N 5/071, A61K 47/48
Applicant:
Otsuka Pharmaceutical Factory, Inc.
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13191663

Vaccine for the prevention of breast cancer relapse

IPC classification:
C07K 7/04, A61K 39/00
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Carpmaels & Ransford LLP
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14166702

Overcoming resistance to ERBB pathway inhibitors

IPC classification:
C07K 16/32, A61K 31/00, A61K 33/00, A61K 39/395
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13706056

APTAMER METHOD

IPC classification:
G01N 33/487, G01N 33/53, G01N 33/543
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13758041

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

IPC classification:
A61P 35/00, A61K 31/7105, A61K 39/395, A61K 48/00
Applicant:
National Cancer Center (Japan)
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11844377

IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH alpha CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM V alpha-J alpha , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS

IPC classification:
A61P 31/00, A61P 35/00, A61P 37/06, A61P 37/08, C07K 14/725, C12N 5/0783, A61K 31/7028, A61K 35/14, A61K 45/06
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11872034

ANTIBODY AGAINST MUTANT alpha-ACTININ-4

IPC classification:
C07K 16/18, C07K 16/30, C12N 5/10, C12N 5/16, C12N 15/02, C12N 15/113, C12P 21/08, C12Q 1/68, G01N 33/574, A61K 39/395, A61K 45/00, A61K 48/00
Applicant:
National Cancer Center (Japan)
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12797050

FLAVIN-BINDING GLUCOSE DEHYDROGENASE, METHOD FOR MANUFACTURING FLAVIN-BINDING GLUCOSE DEHYDROGENASE, AND GLUCOSE MEASUREMENT METHOD USING SAME

IPC classification:
C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 9/04, C12N 15/09, C12Q 1/00, C12Q 1/32, C12Q 1/54
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12771621

DNA VACCINE

IPC classification:
A61P 3/06, A61P 9/12, C07K 14/02, C07K 14/47, C07K 14/575, C12N 15/09, A61K 35/76, A61K 39/00, A61K 39/12, A61K 39/29, A61K 48/00
Applicant:
Osaka University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12818038

TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION

IPC classification:
A61P 25/00, A61P 35/00, A61P 37/08, C12N 5/10, C12N 15/09, A01K 67/027, A61K 31/7105, A61K 31/713, A61K 48/00
Applicant:
Tokyo Institute of Technology
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12872831

HUMANIZED MOUSE

IPC classification:
C12N 15/09, A01K 67/027
Applicant:
Kumamoto University
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13770378

NUCLEIC ACID MOLECULE CAPABLE OF INHIBITING EXPRESSION OF PERIOSTIN GENE, METHOD FOR INHIBITING EXPRESSION OF PERIOSTIN GENE, AND USE OF SAID NUCLEIC ACID MOLECULE

IPC classification:
A61P 27/02, A61P 43/00, C12N 15/09, C12N 15/113, A61K 31/7088, A61K 48/00
Applicant:
Kyushu University
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13718667

COMPOSITIONS AND TREATMENTS BASED ON CADHERIN MODULATION

IPC classification:
A61P 17/02, C12N 15/113, A61K 31/7088
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13711464

MUTANT LYSENIN PORES

IPC classification:
C07K 14/435, C12Q 1/00
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP11731166

ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF

IPC classification:
A61K 39/395
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13782434

CELL PREPARATION CONTAINING MYOCARDIUM-COMMITTED CELL

IPC classification:
A61P 9/00, C12N 5/07, C12N 5/077, A61K 35/36, A61L 27/00
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14194551

Antibodies against Clostridium difficile toxins and uses thereof

IPC classification:
A61P 1/00, A61P 1/12, A61P 31/04, C07K 16/12, C12N 1/15, C12N 1/21, C12N 5/10, C12N 15/13, A61K 39/08, A61K 39/395, A61K 47/48
Applicant:
University of Massachusetts
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13801017

MARKER FOR ACUTE CORONARY SYNDROME, AND USE THEREOF

IPC classification:
G01N 33/53, G01N 33/68
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13731594

WHOLE CELL ASSAYS AND METHODS

IPC classification:
G01N 33/50, G01N 33/574
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14191352

IP-10 antibodies and their uses

IPC classification:
A61P 31/04, A61P 31/12, A61P 37/06, C07K 14/52, C07K 16/24, C12N 5/18, A61K 39/395
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13812775

THERAPEUTIC AGENT FOR ANEMIA INCLUDING RENAL ANEMIA AND CANCER-INDUCED ANEMIA WHICH CONTAINS ANTI-BMP9 ANTIBODY AS ACTIVE INGREDIENT

IPC classification:
C07K 16/18, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13740351

ENZYME CONSTRUCT

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13740348

MODIFIED HELICASES

IPC classification:
C12N 9/12, C12N 9/14
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13742041

SSB METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13826292

IMMUNE CELL ACTIVATION INHIBITOR AND USE THEREOF

IPC classification:
A61P 25/00, A61P 25/16, A61P 25/28, A61P 29/00, A61P 31/04, A61P 37/06, A61K 31/17
Applicant:
Ehime University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13829360

NT-proCNP AS A BIOMARKER OF VASCULAR DISORDERS AND PREGNANCY COMPLICATION

IPC classification:
C07K 16/22, G01N 33/68, A61K 39/00
Applicant:
Otago Innovation Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
GRANT OF PATENT INTENDED
EP13831030

BORON CLUSTER-MODIFIED PEG LIPID DERIVATIVE, AND MOLECULAR ASSEMBLY USING SAME

IPC classification:
C07F 5/05, C07F 9/09, C07F 19/00, C08G 65/328, A61K 9/127, A61K 31/69, A61K 41/00, A61K 47/24, A61K 47/28, A61K 47/34
Applicant:
University of Tsukuba
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
PATENT GRANTED
EP13832195

DIAGNOSIS OF RHEUMATOID ARTHRITIS BY MICRORNA

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/50, G01N 33/53
Applicant:
Kyoto University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13830548

METHOD FOR PRODUCING RETINAL PIGMENT EPITHELIAL CELL SHEET

IPC classification:
A61P 27/02, C12N 5/071, C12N 5/10, A61K 35/44, A61L 27/00
Applicant:
Kabushiki Kaisha Riken
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15151984

Tetramer of extracellular domain of PD-L1

IPC classification:
C07K 14/705, A61K 9/00, A61K 9/19, A61K 38/00, A61K 47/26
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13832772

DNA VACCINE CONTAINING VEGF-SPECIFIC EPITOPE AND/OR ANGIOPOIETIN-2-SPECIFIC EPITOPE

IPC classification:
A61P 35/00, C12N 15/09, A61K 39/00, A61K 48/00
Applicant:
Osaka University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13762540

SAMPLE PREPARATION METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP13837072

METHOD FOR MEASURING CHOLESTEROL CONTAINED IN CHICKEN EGG USING NON-DESTRUCTIVE MEANS

IPC classification:
G01N 21/35, G01N 33/08
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13842351

METHOD FOR IN VITRO PROLIFERATION OF CELL POPULATION CONTAINING CELLS SUITABLE FOR TREATMENT OF ISCHEMIC DISEASE

IPC classification:
A61P 3/10, A61P 9/10, A61P 17/02, C12N 5/077, C12N 5/078, A61K 35/14, A61K 35/28
Applicant:
Tokai University Educational System
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13841056

BNA CLAMP METHOD

IPC classification:
C12N 15/09, C12Q 1/68
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13843070

ANTI-HUMAN DLK-1 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO

IPC classification:
C12N 15/09
Applicant:
LIVTECH, INC.
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13836385

CANCER MARKER AND APPLICATION THEREOF

IPC classification:
A61P 35/00, C07K 14/705, C12N 15/09, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/574, A61K 39/395, A61K 45/00
Applicant:
Gifu University
Applicant:
Kagawa University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13821931

COMBINATION OF AN ANTI-CANCER AGENT SUCH AS A TYROSINEKINASE INHIBITOR AND A STAT5 ANTAGONIST, PREFERABLY A THIAZOLIDINEDIONE, FOR ELIMINATING HEMATOLOGIC CANCER STEM CELLS IN VIVO AND FOR PREVENTING HEMATOLOGIC CANCER RELAPSE

IPC classification:
A61P 35/02, A61K 31/00, A61K 31/404, A61K 31/4439, A61K 31/496, A61K 31/5025, A61K 31/506, A61K 31/517, A61K 31/519, A61K 31/5377
Applicant:
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13852787

METHOD FOR TESTING FOR NEPHRITIS-LESION SITES AND REAGENT THEREFOR

IPC classification:
G01N 33/53
Applicant:
University of Fukui
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13853016

ANTI-ADAM28 ANTIBODY FOR TREATING CANCER

IPC classification:
A61P 35/00, C07K 16/40, C12N 15/09, A61K 39/395
Applicant:
Keio University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13789619

QUADRUPLEX METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP13855272

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES OF INFECTIOUS AND NON-INFECTIOUS ORIGIN

IPC classification:
A61P 11/00, A61P 43/00, G01N 33/573, A61K 38/43
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13860315

ANTI-FOLR1 ANTIBODY

IPC classification:
A61P 35/00, C07K 16/28, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08, G01N 33/574, A61K 39/395
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15169933

SINGLE-STRAND NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION

IPC classification:
C12N 15/11, C12N 15/113
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11796306

ANTI-VEGF ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/22, A61K 39/395
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14740752

METHOD FOR IDENTIFYING CELLS

IPC classification:
C12N 5/0735, C12N 5/074, C12N 5/0775, C12Q 1/68, G01N 33/48, G01N 33/53, G01N 37/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15172601

ANTI-IL-3RA ANTIBODY FOR USE IN TREATMENT OF BLOOD TUMOR

IPC classification:
A61P 35/02, C07K 16/28, C07K 16/46, C12N 15/02, C12N 15/09, C12P 21/08, C12R 1/91, G01N 33/53, G01N 33/574, G01N 33/577, A61K 39/395
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15172997

HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF

IPC classification:
C07K 16/08, G01N 33/569, A61K 39/395
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14702643

ENZYME STALLING METHOD

IPC classification:
C12Q 1/68, G01N 33/487
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14760422

PRSV-RESISTANT CUCUMBER, AND METHOD FOR PRODUCING CUCUMBER EXHIBITING RESISTANCE TO PRSV AND ZYMV

IPC classification:
C12N 15/09, C12Q 1/68, A01H 1/00, A01H 5/00, A01H 5/08
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14764582

METHODS AND COMPOSITIONS FOR ENHANCING OXYGEN LEVELS IN TISSUES

IPC classification:
A61P 7/06, A61P 9/10, A61P 17/02, A61P 31/00, A61P 33/00, A61K 9/00, A61K 9/127, A61K 31/6615
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15710396

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

IPC classification:
A61P 29/00, A61P 37/06, C07K 16/18, C07K 16/40
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
PATENT GRANTED
EP14773935

CELL SORTING METHOD

IPC classification:
A61P 43/00, C12N 5/071, C12N 5/0735, C12N 15/09, A61K 35/12, A61L 27/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14724622

NANOPORE BIOSENSORS FOR DETECTION OF PROTEINS AND NUCLEIC ACIDS

IPC classification:
C07K 14/255
Applicant:
Katholieke Universiteit Leuven
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14722916

COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A THERAPEUTIC AGENT TARGETING COMPLEMENT C5

IPC classification:
C07K 16/18, A61K 39/395, A61K 48/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14720267

ANTI-TUMOR DNA VACCINE

IPC classification:
A61K 39/00
Applicant:
Kyushu University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14785570

ORAL VACCINE HAVING IMPROVED CELLULAR IMMUNITY INDUCTION POTENCY

IPC classification:
A61P 31/12, A61K 35/74, A61K 39/07
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15182059

METHOD OF CHARACTERIZING A TARGET POLYNUCLEOTIDE USING A TRANSMEMBRANE PORE AND MOLECULAR MOTOR

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION REQUESTED
EP12744724

METHOD FOR DIAGNOSING ACUTE LUNG INJURY

IPC classification:
G01N 33/68
Applicant:
Nagasaki University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
The patent has been granted
EP14791230

ATOPIC DERMATITIS MODEL ANIMAL AND USE THEREOF

IPC classification:
C12N 15/09, G01N 33/15, G01N 33/50, A01K 67/027
Applicant:
Mie University
Applicant:
Hyogo College of Medicine
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14795407

METHODS OF TREATING SKIN CONDITIONS USING CYCLOLIGNAN COMPOUNDS

IPC classification:
A61P 17/00, A61P 17/08, A61P 17/10, A61P 17/12, A61P 35/00, C07D 317/00, C07D 323/00, A61K 31/365
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14804893

REAGENT INCLUDING ANTI-LGR6 ANTIBODIES FOR DETECTION AND DIAGNOSIS OF CANCER

IPC classification:
C07K 16/28, C12N 15/09, G01N 33/574, A61K 39/395, A61K 49/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11807967

FLUOROCARBON-LINKED PEPTIDE FORMULATION

IPC classification:
A61K 39/00, A61K 39/145, A61K 39/385
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
The patent has been granted
EP15194590

HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF

IPC classification:
C07K 14/005, C07K 16/08, C12N 15/13, A61K 38/00, A61K 39/00, A61K 39/42
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14813075

ASSAY FOR ANTI-MULLERIAN HORMONE

IPC classification:
G01N 33/53
Applicant:
Otago Innovation Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14819579

ROOT-KNOT NEMATODE RESISTANCE MARKER FOR TOMATO PLANT, ROOT-KNOT NEMATODE RESISTANT TOMATO PLANT, PRODUCTION METHOD FOR ROOT-KNOT NEMATODE RESISTANT TOMATO PLANT, AND SCREENING METHOD FOR ROOT-KNOT NEMATODE RESISTANT TOMATO PLANT

IPC classification:
C12N 15/09, C12Q 1/68, A01H 1/02
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14822858

PRODUCTION METHOD FOR CULTURE CONTAINING VIRUS-LIKE PARTICLES

IPC classification:
C07K 14/08, C12N 7/02
Applicant:
University of Tampere Vaccine Research Center
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14811223

METHOD FOR PRODUCING RENAL PRECURSOR CELLS, AND DRUG CONTAINING RENAL PRECURSOR CELLS

IPC classification:
A61P 13/12, C12N 5/07, C12N 5/077, A61K 35/12, A61L 27/00
Applicant:
Astellas Pharma Inc.
Applicant:
Kyoto University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14761423

MEDICAMENT COMPRISING ANTI-PHOSPHOLIPASE D4 ANTIBODY

IPC classification:
A61P 37/00, C07K 16/40, A61K 39/395
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14822108

PURIFICATION METHOD FOR VIRUS-LIKE PARTICLES

IPC classification:
C07K 1/16, C07K 14/08, C12N 7/02
Applicant:
University of Tampere Vaccine Research Center
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14835131

METHOD FOR PRODUCING ANTERIOR EYE SEGMENT TISSUE

IPC classification:
C12N 5/071, C12N 5/0735
Applicant:
Kabushiki Kaisha Riken
Applicant:
Sumitomo Chemical Company Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14756108

METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14761726

TREATMENT OF GRAFT REJECTION BY ADMINISTERING A COMPLEMENT INHIBITOR TO AN ORGAN PRIOR TO TRANSPLANT

IPC classification:
A61P 37/06, C07K 16/18, C07K 19/00, A61K 38/00, A61K 39/395
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14761393

PROTEIN CRYSTALS

IPC classification:
B82Y 5/00, C07K 1/00, C12N 9/04, C12N 15/62
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
The patent has been granted
EP14838351

METHOD AND SYSTEM FOR SELECTING DRUG ON BASIS OF INDIVIDUAL PROTEIN DAMAGE INFORMATION FOR PREVENTING SIDE EFFECTS OF DRUG

IPC classification:
C12Q 1/68, G01N 33/15
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13165182

Efficient method for displaying protein multimer

IPC classification:
C07K 16/18, C12N 9/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
PATENT GRANTED
EP14843505

CULTURE SYSTEM AND CULTURE METHOD

IPC classification:
C12M 1/00, C12M 3/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14846851

DRUG FOR DISEASE CAUSED BY EXPRESSION OF PERIOSTIN EXCEPT EYE DISEASE, AND USE THEREOF

IPC classification:
A61P 1/00, A61P 11/00, A61P 11/06, A61P 17/00, A61P 17/02, A61P 35/00, C12N 15/113, A61K 31/7088, A61K 35/76, A61K 48/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14772216

METHOD

IPC classification:
G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14851809

METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL

IPC classification:
A61P 27/02, C12N 5/074, C12N 5/0775, C12N 5/10, C12N 15/09, A61K 35/12, A61K 35/44
Applicant:
Osaka University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14852053

METHOD FOR PURIFICATION OF RETINAL PIGMENT EPITHELIAL CELLS

IPC classification:
A61P 27/02, C12N 5/074, C12N 5/0775, C12N 5/10, C12N 15/09, A61K 35/12, A61K 35/44
Applicant:
Osaka University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14853737

HUMAN ANTIBODY AGAINST AGGRECANASE-TYPE ADAMTS SPECIES FOR THERAPEUTICS OF AGGRECANASE-RELATED DISEASES

IPC classification:
A61P 19/02, C07K 16/40, C12N 15/09, A61K 39/395
Applicant:
Keio University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14792535

METHOD OF CHARACTERIZING A TARGET RIBONUCLEIC ACID (RNA) COMPRISING FORMING A COMPLEMENTARY POLYNUCLEOTIDE WHICH MOVES THROUGH A TRANSMEMBRANE PORE

IPC classification:
C12Q 1/68, G01N 33/487
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11825257

MODEL ANIMAL FOR STUDYING HAIR GROWTH CYCLE

IPC classification:
C12N 15/09, G01N 33/50, A01K 67/027
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11818262

REAGENT FOR TUMOR TESTING AND PHARMACEUTICAL COMPOSITION FOR TUMOR PREVENTION

IPC classification:
C12N 15/09, C12N 15/113, C12Q 1/68, G01N 33/53, G01N 33/574, A01K 67/027, A61K 35/00, A61K 35/28, A61K 39/395, A61K 45/00, A61K 48/00
Applicant:
Kyushu University
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14861343

BIOMARKER FOR CARDIAC DISORDERS

IPC classification:
C07K 7/06, C07K 7/08, C07K 16/18, G01N 33/53, G01N 33/68
Applicant:
Otago Innovation Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14863861

METHOD FOR MANUFACTURING TELENCEPHALON OR PROGENITOR TISSUE THEREOF

IPC classification:
C12N 5/079
Applicant:
Sumitomo Chemical Company Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14863258

COMPOSITION FOR EPIMERIZATION OF HEXOSE BIPHOSPHATE, COMPRISING THERMOPHILE-DERIVED SUGAR EPIMERASE

IPC classification:
C12N 1/20, A23L 27/00, A23L 27/30
Applicant:
Kyungpook National University Industry-Academic Cooperation Foundation
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP11816353

METHOD OF INDUCING DIFFERENTIATION FROM PLURIPOTENT STEM CELLS TO GERM CELLS

IPC classification:
C12N 5/071, C12N 5/073, C12N 5/0735, C12N 5/10
Applicant:
Kyoto University
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP15727755

DOSAGE AND ADMINISTRATION ANTI-EGFR THERAPEUTICS

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/30, A61K 39/395, A61K 45/06
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14866371

PEST CONTROL METHOD AND CONTROL DEVICE

IPC classification:
A01M 1/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14870369

METHOD FOR CONTROLLED RELEASE WITH FEMTOSECOND LASER PULSES

IPC classification:
A61K 9/00, A61K 9/127, A61K 47/02
Applicant:
Okinawa Institute of Science and Technology School Corporation
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14873187

CONTINUOUS PRODUCTION METHOD FOR DECOMPOSITION PRODUCT FROM WATER-INSOLUBLE MACROMOLECULAR COMPOUND

IPC classification:
C07K 1/12, C07K 14/435, C07K 14/78, C13K 13/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP16177656

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

IPC classification:
A61P 29/00, A61P 37/06, C07K 16/18, C07K 16/40
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14878653

METHOD FOR MANUFACTURING CILIARY MARGIN STEM CELLS

IPC classification:
A61P 27/02, A61P 43/00, C12N 5/071, C12N 5/074, C12N 5/10, C12Q 1/02, A61K 35/44, A61L 27/00
Applicant:
Kabushiki Kaisha Riken
Applicant:
Sumitomo Chemical Company Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15737214

NOVEL METHOD FOR LABELLING CANCERIZATION-CAUSING CELL IN STEM CELLS, AND THERAPY METHOD

IPC classification:
C12N 5/10, C12N 15/09, C12Q 1/02, C12Q 1/04, C12Q 1/68
Applicant:
Kagoshima University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP10834553

METHOD FOR CONSTRUCTING CHIMERIC RAT USING RAT EMBRYONIC STEM CELLS

IPC classification:
C12N 5/073, C12N 5/0735, C12N 15/85, C12N 15/873, A01K 67/02, A01K 67/027
Applicant:
National Cancer Center (Japan)
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP15704360

METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14776897

METHOD FOR CONTROLLING THE MOVEMENT OF A POLYNUCLEOTIDE THROUGH A TRANSMEMBRANE PORE

IPC classification:
C12Q 1/68, G01N 33/487
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15740593

METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID

IPC classification:
A61P 1/16, A61P 3/04, A61P 3/06, A61P 3/10, C12N 9/88, A61K 31/20, A61K 31/201, A61K 31/202
Applicant:
Kyoto University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15740644

METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID

IPC classification:
C07C 51/373, C07C 59/185, C07C 59/76, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 9/04, C12N 15/09, C12P 7/64
Applicant:
Kyoto University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP12275088

Methods and kits for predicting tumor responses to antibodies against epidermal growth factor receptor (EGFR) and uses thereof

IPC classification:
C07K 16/28, C07K 16/30, G01N 33/574
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16175100

METHOD FOR CUTTING OUT RNA OLIGONUCLEOTIDE

IPC classification:
C07H 21/04, C12N 15/10, C12Q 1/68
Applicant:
Nitto Denko Corporation
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
Request for examination was made
EP15708566

SAMPLE PREPARATION METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15754649

FLAVIN-BINDING GLUCOSE DEHYDROGENASE HAVING IMPROVED SPECIFIC ACTIVITY

IPC classification:
C12M 1/40, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 9/04, C12N 15/09, C12Q 1/32
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP12182252

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61P 21/04, C07H 21/04, C12N 15/11, A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182257

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61P 21/04, C07H 21/04, C12N 15/11, A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182258

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61P 21/04, C07H 21/04, C12N 15/11, A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182249

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61P 21/04, C07H 21/04, C12N 15/11, A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15754683

METHOD FOR FABRICATING CELL AGGREGATE FOR SELF-ORGANIZATION

IPC classification:
C12M 3/00, C12N 5/071, C12N 5/0735, C12N 5/077, C12N 5/0775, C12N 5/10, A61L 27/00
Applicant:
Yokohama City University
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP16189516

USE OF MYELIN BASIC PROTEIN AS A NOVEL GENETIC FACTOR FOR RHEUMATOID ARTHRITIS

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/53, G01N 33/564
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION PUBLISHED
EP15769685

METHOD AND REAGENT FOR EXTRACTING NUCLEIC ACID

IPC classification:
C12N 15/09
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15716116

METHOD FOR CHARACTERISING A DOUBLE STRANDED NUCLEIC ACID USING A NANO-PORE AND ANCHOR MOLECULES AT BOTH ENDS OF SAID NUCLEIC ACID

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15716117

METHOD OF TARGET MOLECULE CHARACTERISATION USING A MOLECULAR PORE

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15773110

FLUORESCENT LABELED SINGLE-STRANDED NUCLEIC ACID AND USE THEREOF

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/542
Applicant:
Kabushiki Kaisha Riken
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15779412

METHOD FOR MEASURING TOXICITY OF HUMAN CSF

IPC classification:
G01N 33/48
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15720770

MUTANT PORES

IPC classification:
C07K 14/35, C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15723994

METHOD OF IMPROVING THE MOVEMENT OF A TARGET POLYNUCLEOTIDE WITH RESPECT TO A TRANSMEMBRANE PORE

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP16743489

ANALYSIS DEVICE, ANALYSIS CHIP, ANALYSIS KIT, AND ANALYSIS METHOD USING SAME

IPC classification:
C12M 1/00, C12M 1/34, C12Q 1/68, G01N 35/08, G01N 37/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15795718

METHOD FOR INDUCING DIFFERENTIATION OF INSULIN-PRODUCING CELLS

IPC classification:
A61P 3/10, C12N 5/0735, C12N 5/074, C12N 5/10, C12N 15/09, C12Q 1/02, G01N 33/15, G01N 33/50, A61K 35/12
Applicant:
Tokyo Institute of Technology
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15796807

NUCLEIC ACID DRUG FOR INDUCING SKIPPING OF VARIANT EXON OF CD44 GENE AND INCREASING EXPRESSION OF NORMAL TYPE CD44 MRNA

IPC classification:
A61P 35/00, A61P 43/00, A61K 31/7088, A61K 31/7115, A61K 31/712, A61K 48/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15803346

METHOD FOR TREATING CANCER PATIENTS USING FOLR1 TARGETED DRUG AND ANTIFOLATE, AND DRUG

IPC classification:
A61P 35/00, A61K 31/519, A61K 39/395, A61K 45/00
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP16188387

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

IPC classification:
A61P 35/00, A61P 37/00, C07K 14/705, C07K 16/28, C12N 5/10, G01N 33/50, A61K 39/395
Applicant:
Genmab A/S
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
Request for examination was made
EP15806911

MULTIPLEX ALLOANTIGENIC PEPTIDE

IPC classification:
A61P 19/00, A61P 25/00, A61P 27/02, A61P 35/00, A61P 37/00, C07K 7/08, C07K 16/42, C07K 17/02, A61K 39/00, A61K 39/39
Applicant:
Kabushiki Kaisha Riken
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP14894697

METHOD FOR DILUTE PLASMA SEPARATION USING CONTAINER FOR BLOOD DILUTION AND STORAGE CONTAINING GELLING AGENT FOR PLASMA SEPARATION

IPC classification:
G01N 33/48
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP16193133

ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF

IPC classification:
A61P 35/00, A61P 37/02, C07K 14/705, C07K 16/28, A01K 67/027, A61K 39/395
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
APPLICATION PUBLISHED
EP15800170

NOVEL LACTIC ACID BACTERIUM AND COMPOSITION INCLUDING SAID LACTIC ACID BACTERIUM

IPC classification:
A61P 3/00, C12N 1/20, C12N 15/09, C12R 1/24, A23L 33/10, A61K 35/747
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15825052

METHOD FOR PRODUCING ADENOHYPOPHYSIS OR PRECURSOR TISSUE THEREOF

IPC classification:
C12N 5/071, C12N 5/0735, C12N 5/079, C12N 5/0797
Applicant:
Kabushiki Kaisha Riken
Applicant:
Sumitomo Chemical Company Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15824166

ANALYSIS METHOD FOR DILUTED BIOLOGICAL SAMPLE COMPONENT

IPC classification:
G01N 33/48, G01N 33/49
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15830033

METHOD FOR PRODUCING RETINAL GANGLION CELLS

IPC classification:
A61P 27/02, A61P 27/06, C12N 5/0735, C12N 5/079, C12N 5/0797, C12N 15/09, C12Q 1/02, A61K 35/12, A61K 35/54, A61L 27/00
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED
EP15759585

USE OF JAGGED 1/FRIZZLED 4 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS

IPC classification:
C12N 5/077
Agent:
Pamela M. Tuxworth, J A Kemp
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature